{"id":"https://openalex.org/W7224490993","doi":"https://doi.org/10.1097/ftd.0000000000001546","title":"Serum Profiles of Pembrolizumab, Cardiac Troponin T, and Interleukin-6 in a Plasma Exchange\u2013Treated Patient With Immune Checkpoint Inhibitor\u2013Related Myocarditis","display_name":"Serum Profiles of Pembrolizumab, Cardiac Troponin T, and Interleukin-6 in a Plasma Exchange\u2013Treated Patient With Immune Checkpoint Inhibitor\u2013Related Myocarditis","publication_year":2026,"publication_date":"2026-10-29","ids":{"openalex":"https://openalex.org/W7224490993","doi":"https://doi.org/10.1097/ftd.0000000000001546","pmid":"https://pubmed.ncbi.nlm.nih.gov/42956192"},"language":"en","primary_location":{"id":"doi:10.1097/ftd.0000000000001546","doi":"https://doi.org/10.1097/ftd.0000000000001546","is_oa":false,"landing_page_url":"https://doi.org/10.1097/ftd.0000000000001546","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000079387","display_name":"Kazumasa Narita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137975476","display_name":"Shinshu University","ror":"https://ror.org/0244rem06","country_code":"JP","type":"education","lineage":["https://openalex.org/I137975476"]},{"id":"https://openalex.org/I4210129652","display_name":"Shinshu University Hospital","ror":"https://ror.org/03a2hf118","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210129652"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazumasa Narita","raw_affiliation_strings":["Department of Clinical Pharmacology and Therapeutics, Shinshu University Graduate School of Medicine, Matsumoto, Nagano, Japan; and","Department of Pharmacy, Shinshu University Hospital, Matsumoto, Nagano, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology and Therapeutics, Shinshu University Graduate School of Medicine, Matsumoto, Nagano, Japan; and","institution_ids":["https://openalex.org/I137975476"]},{"raw_affiliation_string":"Department of Pharmacy, Shinshu University Hospital, Matsumoto, Nagano, Japan;","institution_ids":["https://openalex.org/I4210129652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160145429","display_name":"Sho Suzuki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137975476","display_name":"Shinshu University","ror":"https://ror.org/0244rem06","country_code":"JP","type":"education","lineage":["https://openalex.org/I137975476"]},{"id":"https://openalex.org/I4210129652","display_name":"Shinshu University Hospital","ror":"https://ror.org/03a2hf118","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210129652"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Sho Suzuki","raw_affiliation_strings":["Department of Cardiovascular Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan","institution_ids":["https://openalex.org/I137975476","https://openalex.org/I4210129652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021147223","display_name":"Koichiro Kuwahara","orcid":"https://orcid.org/0000-0003-2670-7170","observed_orcids":["https://orcid.org/0000-0003-2670-7170"]},"institutions":[{"id":"https://openalex.org/I137975476","display_name":"Shinshu University","ror":"https://ror.org/0244rem06","country_code":"JP","type":"education","lineage":["https://openalex.org/I137975476"]},{"id":"https://openalex.org/I4210129652","display_name":"Shinshu University Hospital","ror":"https://ror.org/03a2hf118","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210129652"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Koichiro Kuwahara","raw_affiliation_strings":["Department of Cardiovascular Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan","institution_ids":["https://openalex.org/I137975476","https://openalex.org/I4210129652"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088243776","display_name":"Takafumi Naito","orcid":"https://orcid.org/0000-0002-7447-3789","observed_orcids":["https://orcid.org/0000-0002-7447-3789"]},"institutions":[{"id":"https://openalex.org/I137975476","display_name":"Shinshu University","ror":"https://ror.org/0244rem06","country_code":"JP","type":"education","lineage":["https://openalex.org/I137975476"]},{"id":"https://openalex.org/I4210129652","display_name":"Shinshu University Hospital","ror":"https://ror.org/03a2hf118","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210129652"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takafumi Naito","raw_affiliation_strings":["Department of Clinical Pharmacology and Therapeutics, Shinshu University Graduate School of Medicine, Matsumoto, Nagano, Japan; and","Department of Pharmacy, Shinshu University Hospital, Matsumoto, Nagano, Japan;"],"raw_orcid":"https://orcid.org/0000-0002-7447-3789","affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology and Therapeutics, Shinshu University Graduate School of Medicine, Matsumoto, Nagano, Japan; and","institution_ids":["https://openalex.org/I137975476"]},{"raw_affiliation_string":"Department of Pharmacy, Shinshu University Hospital, Matsumoto, Nagano, Japan;","institution_ids":["https://openalex.org/I4210129652"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.8375854,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11112","display_name":"Viral Infections and Immunology Research","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9890000224113464},{"id":"https://openalex.org/keywords/therapeutic-plasma-exchange","display_name":"plasma exchange","score":0.9559999704360962},{"id":"https://openalex.org/keywords/cardiac-troponin-t","display_name":"cardiac troponin T","score":0.9139999747276306},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":1.0},{"id":"https://openalex.org/keywords/myasthenia-gravis","display_name":"myasthenia gravis","score":0.9470000267028809},{"id":"https://openalex.org/keywords/serum-drug-levels","display_name":"serum drug concentration","score":0.6909999847412109},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.8880000114440918},{"id":"https://openalex.org/keywords/methylprednisolone","display_name":"methylprednisolone","score":0.8040000200271606}],"concepts":[{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.9365000128746033},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8733999729156494},{"id":"https://openalex.org/C2780875844","wikidata":"https://www.wikidata.org/wiki/Q186235","display_name":"Myocarditis","level":2,"score":0.7067999839782715},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6000000238418579},{"id":"https://openalex.org/C8880881","wikidata":"https://www.wikidata.org/wiki/Q7846262","display_name":"Troponin complex","level":4,"score":0.593500018119812},{"id":"https://openalex.org/C2778105408","wikidata":"https://www.wikidata.org/wiki/Q8285","display_name":"Myasthenia gravis","level":2,"score":0.4625999927520752},{"id":"https://openalex.org/C36036425","wikidata":"https://www.wikidata.org/wiki/Q7846262","display_name":"Troponin","level":3,"score":0.439300000667572},{"id":"https://openalex.org/C115725540","wikidata":"https://www.wikidata.org/wiki/Q7846263","display_name":"Troponin I","level":3,"score":0.35929998755455017},{"id":"https://openalex.org/C144469398","wikidata":"https://www.wikidata.org/wiki/Q24785650","display_name":"Troponin T","level":3,"score":0.3555999994277954},{"id":"https://openalex.org/C2780372218","wikidata":"https://www.wikidata.org/wiki/Q417222","display_name":"Methylprednisolone","level":2,"score":0.3528999984264374},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3499000072479248},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3425999879837036},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.33399999141693115},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3151000142097473},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.29249998927116394},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2547000050544739}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1097/ftd.0000000000001546","doi":"https://doi.org/10.1097/ftd.0000000000001546","is_oa":false,"landing_page_url":"https://doi.org/10.1097/ftd.0000000000001546","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},{"id":"pmid:42956192","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42956192","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic drug monitoring","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W2303464565","https://openalex.org/W2589627860","https://openalex.org/W2793167197","https://openalex.org/W2903468548","https://openalex.org/W2936825025","https://openalex.org/W2962945166","https://openalex.org/W2976692781","https://openalex.org/W3103439105","https://openalex.org/W3143335905","https://openalex.org/W4396614648","https://openalex.org/W4399788660"],"related_works":["https://openalex.org/W3103439105","https://openalex.org/W4382798856","https://openalex.org/W3016040222","https://openalex.org/W3208609423","https://openalex.org/W4413110473","https://openalex.org/W3135053399","https://openalex.org/W4389731030","https://openalex.org/W4390952559","https://openalex.org/W4415793947","https://openalex.org/W3184135458"],"abstract_inverted_index":{"BACKGROUND:":[0],"A":[1],"77-year-old":[2],"female":[3],"patient":[4,74,143,216,243],"with":[5,10,63,76,130,217,244],"renal":[6],"cell":[7],"carcinoma,":[8],"treated":[9,75],"intravenous":[11,24],"pembrolizumab,":[12,40,179],"developed":[13,227],"pembrolizumab-related":[14],"myocarditis":[15,67,228],"accompanied":[16,229],"by":[17,230],"myasthenia":[18,21,209,231],"gravis.":[19,232],"For":[20],"gravis-related":[22,210],"symptoms,":[23],"methylprednisolone":[25],"was":[26,46,90,103,205],"administered":[27],"on":[28,48,118,153,183],"days":[29,49,93],"24-26":[30],"and":[31,41,53,68,98,116,124,159,167,181,192,239],"29-31":[32],"after":[33,94,200,207],"the":[34,72,95,99,107,111,134,142,156,172,223],"administration":[35],"of":[36,39,66,87,114,133,150,178,203],"200":[37],"mg":[38],"plasma":[42],"exchange":[43],"(PE)":[44],"therapy":[45,234],"conducted":[47],"24,":[50],"26,":[51],"28,":[52],"30.":[54],"METHODS:":[55],"Serum":[56],"pembrolizumab":[57,101,136,148,220,238],"levels":[58,113,161,177],"were":[59,121],"monitored":[60],"in":[61,71,128,241],"conjunction":[62,129],"serum":[64,81,100,112,135,147,157,176,219],"markers":[65],"interleukin-6":[69],"(IL-6)":[70],"present":[73],"PE.":[77],"RESULTS:":[78],"An":[79],"elevated":[80],"cardiac":[82],"troponin":[83],"T":[84],"(cTnT)":[85],"level":[86,102,137,149,221],"0.542":[88],"ng/mL":[89,123,166],"observed":[91],"24":[92],"first":[96,108],"administration,":[97],"15.7":[104],"\u00b5g/mL.":[105,140],"After":[106,171],"PE":[109,174,204,233],"session,":[110,175],"cTnT":[115,158],"IL-6":[117,160,182,240],"day":[119,154,184],"25":[120],"0.406":[122],"27.9":[125],"pg/mL,":[126,169,194],"respectively,":[127],"a":[131,145,218],"decline":[132],"to":[138,164,187],"4.83":[139],"Although":[141],"had":[144,162],"decreased":[146,186],"3.86":[151],"\u00b5g/mL":[152],"29,":[155],"increased":[163],"0.843":[165],"40.6":[168],"respectively.":[170,195],"fourth":[173],"cTnT,":[180],"31":[185],"3.62":[188],"\u00b5g/mL,":[189],"0.381":[190],"ng/mL,":[191],"10.1":[193],"The":[196],"overall":[197],"removal":[198],"rate":[199],"4":[201],"sessions":[202],"76.9%,":[206],"which":[208],"symptoms":[211],"gradually":[212],"disappeared.":[213],"CONCLUSIONS:":[214],"This":[215],"within":[222],"previously":[224],"reported":[225],"range":[226],"efficiently":[235],"extracted":[236],"circulating":[237],"this":[242],"immune":[245],"checkpoint":[246],"inhibitor-related":[247],"myocarditis.":[248]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2026-10-30T00:00:00"}